High temperature crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane
View Patent ↗A method of crystallizing an epsilon-polymorph of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.0 5,9 0 3,11 ]-dodecane (CL-20). The method comprises combining the CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution. The crystallization solution is saturated and heated to a temperature greater than about 60° C., such as from about 71° C. to about 94° C. The organic solvent is removed from the crystallization solution while retaining a sufficient amount of the nonsolvent to crystallize the CL-20 as the epsilon-polymorph. The nonsolvent is separated from the epsilon-polymorph of CL-20. A composition of CL-20 comprising the epsilon-polymorph having a particle density of 2.035 g/ml is also disclosed.
1. A method of crystallizing an epsilon-polymorph of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.0 5,9 0 3,11 ]-dodecane (CL-20), comprising:
combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution;
saturating the crystallization solution;
heating the crystallization solution to a temperature of from about 71° C. to about 94° C.;
removing the at least one organic solvent from the crystallization solution while retaining a sufficient amount of the at least one nonsolvent to crystallize the CL-20 as the epsilon-polymorph; and
separating the at least one nonsolvent from the epsilon-polymorph of CL-20.
2. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20 with at least one organic solvent and at least one nonsolvent that are miscible with each other.
3. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20 with an effective amount of the at least one organic solvent to dissolve the CL-20.
4. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, the at least one organic solvent, and at least one nonsolvent having a boiling point at least 10° C. higher than a boiling point of the at least one organic solvent.
5. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, the at least one organic solvent, and at least one nonsolvent having a boiling point at least 15° C. higher than a boiling point of the at least one organic solvent.
6. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, the at least one organic solvent, and at least one nonsolvent having a boiling point at least 20° C. higher than a boiling point of the at least one organic solvent.
7. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, ethyl acetate as the at least one organic solvent, and a formate or an acetate as the at least one nonsolvent.
8. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, ethyl acetate as the at least one organic solvent, and benzyl formate as the at least one nonsolvent.
9. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, ethyl acetate as the at least one organic solvent, and benzyl acetate as the at least one nonsolvent.
10. The method of claim 1 , wherein combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution comprises combining the CL-20, the at least one organic solvent, and at least one nonsolvent comprising at least one ester selected from the group consisting of an aryl formate and an aryl acetate.
11. The method of claim 1 , wherein saturating the crystallization solution comprises evaporating the at least one organic solvent until a saturated or a supersaturated crystallization solution is formed.
12. The method of claim 1 , wherein saturating the crystallization solution comprises adding additional CL-20 to the crystallization solution until a saturated or a supersaturated crystallization solution is formed.
13. The method of claim 1 , wherein removing the at least one organic solvent from the crystallization solution comprises evaporating the at least one organic solvent.
14. The method of claim 1 , further comprising adding a co-nonsolvent to the crystallization solution.
15. The method of claim 14 , wherein adding a co-nonsolvent to the crystallization solution comprises adding naphthenic oil or paraffinic oil to the crystallization solution.
16. The method of claim 14 , wherein adding a co-nonsolvent to the crystallization solution comprises adding the co-nonsolvent to the crystallization solution in a weight ratio that ranges from about 20:80 of the co-nonsolvent to the at least one nonsolvent to about 60:40 of the co-nonsolvent to the at least one nonsolvent.
17. The method of claim 1 , further comprising adding epsilon-polymorph CL-20 seed crystals to the crystallization solution.
18. The method of claim 17 , further comprising growing the epsilon-polymorph of CL-20 from the crystallization solution onto the epsilon-polymorph CL-20 seed crystals.
19. A method of crystallizing an epsilon-polymorph of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.0 5,9 0 3,11 ]-dodecane (CL-20)>comprising:
combining CL-20, at least one organic solvent, and at least one nonsolvent to form a crystallization solution;
saturating the crystallization solution;
heating the crystallization solution to a temperature of from about 71° C. to about 130° C.;
removing the at least one organic solvent from the crystallization solution while retaining a sufficient amount of the at least one nonsolvent to crystallize the CL-20 as the epsilon-polymorph; and
separating the at least one nonsolvent from the epsilon-polymorph of CL-20.